During the past decade, Scott Ubillos, MD conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Scott Ubillos, MD" are "HIV Infection" (2 trials) and "HIV Seropositivity" (2 trials). Many other conditions were trialed in "Scott Ubillos, MD" in a lesser frequency.

Most popular intervention types in "Scott Ubillos, MD" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "poly I-poly C12U" (2 trials). Other intervention names were less common.

The vast majority of trials in "Scott Ubillos, MD" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Scott Ubillos, MD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Scott Ubillos, MD, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Scott Ubillos, MD, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".